pravastatin has been researched along with campesterol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miettinen, TA; Vanhanen, H | 1 |
| Braesen, JH; Gebhardt, A; Harsch, M; Lang, G; Löser, R; Niendorf, A; Reymann, A; Schliack, M | 1 |
| Antikainen, M; Gylling, H; Hedman, M; Ketomäki, A; Miettinen, TA | 1 |
| Gerloff, T; Johne, A; Lütjohann, D; Mwinyi, J; Roots, I; Schaefer, M; Sudhop, T; von Bergmann, K | 1 |
| Buckley, BM; Ford, I; Jukema, JW; Lichtenstein, AH; Matthan, NR; Packard, C; Resteghini, N; Robertson, M; Schaefer, EJ; Shepherd, J | 1 |
2 trial(s) available for pravastatin and campesterol
| Article | Year |
|---|---|
Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.
Topics: Adolescent; Anticholesteremic Agents; Child; Cholestanol; Cholesterol; Desmosterol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 2006 |
Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial.
Topics: Aged; Aged, 80 and over; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Desmosterol; Female; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 2010 |
3 other study(ies) available for pravastatin and campesterol
| Article | Year |
|---|---|
Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Desmosterol; Female; Humans; Hyperlipoproteinemia Type II; Isomerism; Lovastatin; Male; Middle Aged; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 1992 |
Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Heterozygote; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Immunohistochemistry; Intestinal Absorption; Liver; Phytosterols; Polymerase Chain Reaction; Pravastatin; Rabbits; Receptors, LDL; RNA, Messenger | 1998 |
Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Haplotypes; Humans; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Organic Anion Transporters; Phytosterols; Pravastatin | 2006 |